- Home
- XNCR vs GABC Comparison
XNCR vs GABC Comparison
Compare XNCR & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- GABC
- Stock Information
- Founded
- XNCR 1997
- GABC 1910
- Country
- XNCR United States
- GABC United States
- Employees
- XNCR N/A
- GABC N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- GABC Major Banks
- Sector
- XNCR Health Care
- GABC Finance
- Exchange
- XNCR Nasdaq
- GABC Nasdaq
- Market Cap
- XNCR 1.5B
- GABC 1.2B
- IPO Year
- XNCR 2013
- GABC N/A
- Fundamental
- Price
- XNCR $24.10
- GABC $45.08
- Analyst Decision
- XNCR Strong Buy
- GABC Buy
- Analyst Count
- XNCR 8
- GABC 3
- Target Price
- XNCR $35.50
- GABC $44.33
- AVG Volume (30 Days)
- XNCR 569.4K
- GABC 94.1K
- Earning Date
- XNCR 11-06-2024
- GABC 10-28-2024
- Dividend Yield
- XNCR N/A
- GABC 2.40%
- EPS Growth
- XNCR N/A
- GABC N/A
- EPS
- XNCR N/A
- GABC 2.77
- Revenue
- XNCR $85,164,000.00
- GABC $247,156,000.00
- Revenue This Year
- XNCR N/A
- GABC N/A
- Revenue Next Year
- XNCR $86.53
- GABC $37.29
- P/E Ratio
- XNCR N/A
- GABC $16.22
- Revenue Growth
- XNCR N/A
- GABC N/A
- 52 Week Low
- XNCR $15.31
- GABC $27.23
- 52 Week High
- XNCR $26.84
- GABC $46.75
- Technical
- Relative Strength Index (RSI)
- XNCR 70.71
- GABC 62.20
- Support Level
- XNCR $22.60
- GABC $44.50
- Resistance Level
- XNCR $23.86
- GABC $46.33
- Average True Range (ATR)
- XNCR 0.83
- GABC 1.24
- MACD
- XNCR 0.05
- GABC -0.04
- Stochastic Oscillator
- XNCR 96.85
- GABC 75.51
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The Company's lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.